Skip to Content

Ozenoxacin Approval Status

  • FDA approved: No
  • Generic name: ozenoxacin
  • Dosage form: Cream
  • Company: Medimetriks Pharmaceuticals, Inc.
  • Treatment for: Impetigo

Ozenoxacin cream is a topical non-fluorinated quinolone in development for the treatment of impetigo.

Development Status and FDA Approval Process for ozenoxacin

DateArticle
Jun 27, 2016Medimetriks Pharmaceuticals, Inc. Submits NDA to FDA for Ozenoxacin Cream for Impetigo
Aug  2, 2015Cipher Pharmaceuticals Announces Successful Completion of Second Phase III for Ozenoxacin
Jun  5, 2013Ferrer successfully completes a phase III clinical trial in adult and paediatric patients with impetigo for novel antibacterial compound Ozenoxacin
Oct  5, 2012Ferrer Successfully Completes An Absorption, Tolerability and Safety Study in Juveniles As Young As Two Months of Age for Novel Antibacterial Compound Ozenoxacin

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide